Michele Tana grew up in Northern Virginia, studied the Classics at Harvard College, and attended Harvard Medical School. She trained in Internal Medicine at Stanford University Hospital and Clinics and Gastroenterology at California Pacific Medical Center. She was a Hepatology Fellow at the National Institutes of Health in the National Institute of Diabetes and Digestive and Kidney Diseases and earned a Masters Degree in Clinical Research from Duke University.
Dr. Tana joined the UCSF faculty in 2013. She serves the vulnerable patient population at Zuckerberg San Francisco General Hospital and teaches UCSF students and trainees. She directs the Gastroenterology Rotation for Surgery Residents and serves as a Hepatitis C Consultant for the National Clinician Consultation Center. In 2018, she helped launch Prospective Observational Study to Understand Liver Diseases (POSULD). Her team collaborates with researchers across disciplines and across the globe to apply state-of-the-art science and technology to liver diseases, with a focus on health equity in autoimmune hepatitis.